M
Mira Pharmaceuticals, Inc.
Profile managed by Bizz IdMIRA Pharmaceuticals
Estados Unidos
1-10 employees
Description
Clinical-stage pharmaceutical company listed on NASDAQ (MIRA) with two neuroscience programs. Develops MIRA1a, a synthetic THC analog for anxiety and cognitive decline, and Ketamir-2, an oral ketamine analog for treatment-resistant depression and major depressive disorder with suicidal ideation.